Join
Live feed
·
INSIDERFilingvia Quantisnow
Aurinia Pharmaceuticals Inc logo

Director Smith Karen L. converted options into 17,913 shares and sold $44,182 worth of shares (5,241 units at $8.43) (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
AUPH· Aurinia Pharmaceuticals Inc
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track AUPH (Aurinia Pharmaceuticals Inc) and more on Quantisnow.